Skye Bioscience, Inc. (SKYE)

1.80 +0.02 (+1.12%) USD  |  NASDAQ  |  Sep 04, 16:00
1.86 +0.06 (+3.33%) After-Hours: 19:37
More

Skye Bioscience Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for SKYE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Total Expenses (% of Annual Revenues) Data

View and export this data back to 2012. Start Trial.
Date Value
October 31, 2013 --
Date Value
October 31, 2012 --

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. Upgrade
Viking Therapeutics, Inc. --
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Anika Therapeutics, Inc. Upgrade